In collaborative grants, a growing Phase I/II Clinical trials program (see below) and a fertile transference of ideas across disciplines that will lead to even greater success in both applied and clinical research. This effort has resulted in collaborative research grants and projects with scientists in the National Cancer Institute of Canada (NCIC) and other institutions in B.C. and across the country. This is potentially the greatest strength of the BC Cancer Agency multidisciplinary AT team.